James Dyett, OpenAI's Head of Sales who joined during the company's rapid growth phase in 2023, announced his departure to take a new role as Operator in Residence at venture capital firm Thrive Capital. Dyett led key sales efforts including enterprise and API sales at OpenAI, which is now valued at over $850 billion. His exit follows several recent leadership changes at OpenAI, including medical leaves and role transitions among top executives. Dyett expressed enthusiasm for supporting startups at Thrive, a long-term backer of OpenAI, signaling a shift back to early-stage company building for him.
The Dolphin Company's current management proposed selling its main assets in Mexico to Delphinus Blue Planet, a Grupo Xcaret subsidiary, for $20 million. This deal would give Delphinus control over more than 90% of dolphin habitats in Mexico, creatin...
Johnson & Johnson has reached a historic $5.5 billion settlement to resolve claims from about 70,000 women and families alleging its talc products, including Johnson's Baby Powder, contained asbestos and caused cancers such as ovarian cancer and meso...
Catalyst Acquisition Corp. announced the pricing of its initial public offering (IPO) at $10 per unit, raising $200 million by offering 20 million units. The units, each including one Class A ordinary share and a partial share right, will begin tradi...
Willow Tree Research initiates coverage of Immunovant with a BUY rating and a $50 price target, driven by optimism about its drug IMVT-1402. The drug shows strong reduction in IgG with minimal side effects, potentially making it best-in-class, especi...
Elevra Lithium reported a strong June quarter with North American Lithium achieving its second-best quarterly production and a new monthly record in May. The company improved plant recoveries and maintained high mill utilization. Strategically, Elevr...
